relmor,
Good job with the trend analysis....man you are good.
Printable View
B. The Principal of the Broker-Dealer orchestrated a manipulative scheme designed to increase and/or stabilize the prices of a number of the biotechnology securities that the Broker-Dealer took public and in which it made a market. These securities included BioSepra, Inc. ("BioSepra") common stock, Intelligent Surgical Lasers, Inc. ("Intelligent Surgical") Class A warrants, HemaSure, Inc. ("HemaSure") common stock, Ariad Pharmaceuticals, Inc. ("Ariad") units, Ecogen, Inc. ("Ecogen") common stock and MicroProbe Corporation ("MicroProbe") common stock and warrants (the "biotechnology stocks"). For instance, from July through September 1994, the Principal knowingly executed hundreds of transactions in biotechnology stocks. The Principal routinely sold biotechnology stocks from the Broker-Dealer's inventory accounts to brokerage accounts the Principal controlled that were in the names of other individuals and entities. These controlled accounts would then sell the biotechnology stocks back to the brokerage firm or to other accounts controlled by the Principal. Additionally, the Principal engaged in other practices such as wash sales and matched orders in the biotechnology stocks. The Principal also engaged in unauthorized trading in customer accounts. These trades created the appearance of active trading in the biotechnology stocks. Additionally, through this trading, the Principal was also able to reduce the Broker-Dealer's inventory position in the biotechnology stocks, yet still artificially withhold from the market the supply of the biotechnology stocks.
http://www.sec.gov/litigation/admin/33-7927.htm
Hi, Yes if I could figure out how to get started. My sense of humor is kind of dry (like Bob Newhart)
My favorite joke only works if I tell it to people who know a little history (I am a grognard)
Miss Browns 3rd grade class was discussing WWII. She had a old pilot who flew in Battle of Britian come in to tell them about it.
Pilot: "Well one morning I was flying patrol over the channel when this fokker came out of the sun and latched onto me tail"
Class: "giggles at word "fokker"
Pilot: "I tried a weave right but the fokker stuck right with me"
Class: giggles at "fokker"
Pilot: I tried a weave left but the bloody fokker was still blasting me"
Class: giggles at "fokker"
Miss Brown: "Class there was a airplane company named "Fokker" that produced aircraft in WWII"
Pilot: "Thats true Miss but this fokker was flying a Messerschmitt "
dmo..
MM's are incestuous and have no chinese wall. They get away with murder and not a damn thing the SEC can or will ever do about it. They are the kings of their domain and rule as such..throw out all perceived rules as to what they can do, cause there are very few by which they are bound...
Sirius_Long_Hauler, this is most likely the reason follow this link:
http://news.yahoo.com/s/nm/20090304/...kets_stocks_47
guys....................The Big Blue Dog has arrived................... nice digs..................Cos you might want to get that cleaned up.................. the Dog just wet on the left leg of your spacesuit. He was anxious to mark out his new territory............ he does look pretty apologetic...................... but, no...... I swear, I just caught him grinnin............. ...killer.
B. The Principal of the Broker-Dealer orchestrated a manipulative scheme designed to increase and/or stabilize the prices of a number of the biotechnology securities that the Broker-Dealer took public and in which it made a market. These securities included BioSepra, Inc. ("BioSepra") common stock, Intelligent Surgical Lasers, Inc. ("Intelligent Surgical") Class A warrants, HemaSure, Inc. ("HemaSure") common stock, Ariad Pharmaceuticals, Inc. ("Ariad") units, Ecogen, Inc. ("Ecogen") common stock and MicroProbe Corporation ("MicroProbe") common stock and warrants (the "biotechnology stocks"). For instance, from July through September 1994, the Principal knowingly executed hundreds of transactions in biotechnology stocks. The Principal routinely sold biotechnology stocks from the Broker-Dealer's inventory accounts to brokerage accounts the Principal controlled that were in the names of other individuals and entities. These controlled accounts would then sell the biotechnology stocks back to the brokerage firm or to other accounts controlled by the Principal. Additionally, the Principal engaged in other practices such as wash sales and matched orders in the biotechnology stocks. The Principal also engaged in unauthorized trading in customer accounts. These trades created the appearance of active trading in the biotechnology stocks. Additionally, through this trading, the Principal was also able to reduce the Broker-Dealer's inventory position in the biotechnology stocks, yet still artificially withhold from the market the supply of the biotechnology stocks.
http://www.sec.gov/litigation/admin/33-7927.htm
Market Manipulation Practices
Wash Sales
73. A wash sale involves a person, either directly or indirectly, being both the buyer and seller of securities in the same transaction, that is there is no actual change in ownership of the securities. The manipulator will undertake frequent trades hoping to attract other investors who note the increased turnover in the security. The manipulator aims to gain financially through creating a small price differential between the buy and sell rates of the security in question.
Runs
74. A run involves a person creating activity in a security by successively buying (or selling) that security. The intention is that the increased activity would, in the case where the person is buying, attract others to buy and push up the price. At that point, those organising the run would then attempt to sell out at a financial gain. This is sometimes known as "pumping and dumping."
Marking the Close
77. Marking the close is making a purchase or sale of a security near the close of the day's trading in an effort to alter the closing price of the security. This might be done to avoid margin calls (when the trader's position is not self-financed), to support a flagging price or to affect the valuation of a portfolio (called "window dressing"). A common indicator is trading in small parcels of the security just before the market closes.
http://www.med.govt.nz/templates/Mul...spx#P195_36373
I haven't spoken up because I have really enjoyed your comments. Now here comes the difficult part for me.... I am a democrat with some republican views. Ok, let me have it....BOOOO, HISSSSSSS, HISSSSSS, WE HATE YOU!!!!...... Ok, is everyone done? Good, now let me explain why I wanted join part of this convo. First, let me give you alittle bit of my "sirius" background. I currently own 1.2 million shares with a cost avg of .095, but I do not consider myself as long, although a few of you here are doing a good job of persuading me to become one through your educated discussions.!!!:D
I have enjoyed the xm programming then moved over to sirius....and here I am. I only have 3 subs, but truly enjoy the service and my family does also. Ok, the point is that I would have never have bought this stock, but because of Rel, cos,s162, koop, killer ,blue and the rest, I would be sitting on the sidelines....So thank you.
I kinda, sorta, think that I know how loans work (won't go there..pls don't ask) and I can't believe that Mr. Malone would EVER go into that deal without a certain assurance that he would not make out well. Please don't confuse covering his loan vs. making money. He is in the business of making money, not a loan officer. I am with Relmore when he mention that this is a done deal. KPMG is good...JPM is good......COH may be alittle less then we think, but good. Our main concern is 1Q, but siriusxm will deal with that in thier own typical way....SLOOOOOOOOOOOOWLY.
In the words of the great Wayne Gretzsky, " I skate to where the puck is going to be, not where it has been". Ok, let me have it.